Abrams’ Clinical Drug Therapy Rationales for Nursing Practice
12th Edition TEST BANK by Geralyn Frandsen,
A Client Asks A Nurse About Generic Medications. Which Of The Following Are True
Regarding Generic Medications ( Select All That Apply)
A. Have The Potential For Abuse & Dependence
B. Have The Same Chemical Composition As The Brand Name Medication
C. May Have Several Brand Names
D. May Have Several Generic Names
E. Are Usually Less Expensive Than A Brand Name Medication - ANSWER:A,B,C,E
Metabolism
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:A
Absorption
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:D
Distribution
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:B
Excretion
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
,B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:C
Peak Medication Level
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:C
Onset Of Action
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:D
Duration Of Action
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:A
Trough Medication Level
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:B
You Note That A Primary Care Provider Prescribed Morphine Sulfate, An Opioid
Agonist, To Relieve A Clients Postoperative Pain. Which Of The Following Actions
Describes The Action Of An Agonist On A Receptor
A. Destroys The Receptor
B. Competes With The Receptor
C. Activates The Receptor
D. Blocks The Receptor - ANSWER:C
A Nurse Is Caring For A Client Who Has A New Prescription For A Medication. After
Receiving The First Dose Of A Medication, The Client Experiences Anaphylaxis. The
Nurse Should Identify That Anaphylaxis Represents Which Of The Following Results
Of The Medication
, A. Adverse Effect
B. Paradoxical Effect
C. Therapeutic Effect
D. Toxicity - ANSWER:A
A Client Who Has Glaucoma Asks About Taking Oxybutynin, A Muscarinic Antagonist,
To Manage An Overactive Bladder. The Nurse Explains That Glaucoma Is A
Contraindication For Taking Oxybutynin. Primary Care Provides Should Not Prescribe
Contraindicated Medications Because Of Their Potential For Which Of The Following
A. Serious Adverse Reactions
B. Medication Tolerance
C. Medication Dependence
D. Interactions With Other Medications - ANSWER:A
A Nurse Is Talking With A Client About Taking Tetracycline Along With An Antacid.
The Nurse Tells The Client Not To Take These Two Medications At The Same Time
Because The Antacid Can Reduce The Absorption Of Tetracycline. Which Of The
Following Describes The Action Of One Medication Reducing The Effect Of Another
Medication
A. Allergic Reaction
B. Synergistic Effect
C. Antagonistic Effect
D. Adverse Reaction - ANSWER:C
A Nurse Is Preparing To Teach A Client About A Newly Prescribed Medication. Prior
To Providing Teaching, The Nurse Should Review The Precautions Section Of A
Medication Resource For Which Of The Following Reasons
A. Medication Food Interaction
B. If Dosage Modification Is Indicated
C. How The Medication IS Absorbed
D. Availability - ANSWER:B
Primary Care Providers Prescribe Medication Dosages For Children Using Which Of
The Following Information ( Select All That Apply)
A. Body Surface Area
B. Age
C. Weight
D. Developmental Age
E. Medication Properties - ANSWER:A,B,C,E
A Nurse Is Providing Teaching For A Client Who Has A New Prescription For A
Medication With A High Potential For Toxicity. Which Of The Following Information
Should The Nurse Include (Select All That Apply)
A. Periodic Laboratory Tests Are Essential To Measure Serum Medication Level &
Appropriate Dosage
B. Monitoring For Indications Of Toxicity Is Important
12th Edition TEST BANK by Geralyn Frandsen,
A Client Asks A Nurse About Generic Medications. Which Of The Following Are True
Regarding Generic Medications ( Select All That Apply)
A. Have The Potential For Abuse & Dependence
B. Have The Same Chemical Composition As The Brand Name Medication
C. May Have Several Brand Names
D. May Have Several Generic Names
E. Are Usually Less Expensive Than A Brand Name Medication - ANSWER:A,B,C,E
Metabolism
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:A
Absorption
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:D
Distribution
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:B
Excretion
A. The Change Of A Medication Into A More Or Less Potent Or More Soluble Form
After It Passes Through The Liver, Kidneys, Intestinal Mucosa, Or Other Body Part
,B. The Movement Of A Medication By The Circulatory System To Its Intended Site Of
Action
C. The Removal Of The Medication Or Its Metabolites Through The Kidney,
Gastrointestinal Tract, Skin, Or Lungs
D. The Movement Of A Medication From The Site Of Administration Into The
Circulatory System - ANSWER:C
Peak Medication Level
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:C
Onset Of Action
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:D
Duration Of Action
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:A
Trough Medication Level
A. The Length Of Time The Medications Therapeutic Effects Lasts
B. The Point In Time When A Medication Is At Its Lowest Level In The Body
C. The Time It Takes A Medication To Demonstrate Its Full Therapeutic Effect
D. The Time It Takes For A Medication To Demonstrate A Therapeutic Response -
ANSWER:B
You Note That A Primary Care Provider Prescribed Morphine Sulfate, An Opioid
Agonist, To Relieve A Clients Postoperative Pain. Which Of The Following Actions
Describes The Action Of An Agonist On A Receptor
A. Destroys The Receptor
B. Competes With The Receptor
C. Activates The Receptor
D. Blocks The Receptor - ANSWER:C
A Nurse Is Caring For A Client Who Has A New Prescription For A Medication. After
Receiving The First Dose Of A Medication, The Client Experiences Anaphylaxis. The
Nurse Should Identify That Anaphylaxis Represents Which Of The Following Results
Of The Medication
, A. Adverse Effect
B. Paradoxical Effect
C. Therapeutic Effect
D. Toxicity - ANSWER:A
A Client Who Has Glaucoma Asks About Taking Oxybutynin, A Muscarinic Antagonist,
To Manage An Overactive Bladder. The Nurse Explains That Glaucoma Is A
Contraindication For Taking Oxybutynin. Primary Care Provides Should Not Prescribe
Contraindicated Medications Because Of Their Potential For Which Of The Following
A. Serious Adverse Reactions
B. Medication Tolerance
C. Medication Dependence
D. Interactions With Other Medications - ANSWER:A
A Nurse Is Talking With A Client About Taking Tetracycline Along With An Antacid.
The Nurse Tells The Client Not To Take These Two Medications At The Same Time
Because The Antacid Can Reduce The Absorption Of Tetracycline. Which Of The
Following Describes The Action Of One Medication Reducing The Effect Of Another
Medication
A. Allergic Reaction
B. Synergistic Effect
C. Antagonistic Effect
D. Adverse Reaction - ANSWER:C
A Nurse Is Preparing To Teach A Client About A Newly Prescribed Medication. Prior
To Providing Teaching, The Nurse Should Review The Precautions Section Of A
Medication Resource For Which Of The Following Reasons
A. Medication Food Interaction
B. If Dosage Modification Is Indicated
C. How The Medication IS Absorbed
D. Availability - ANSWER:B
Primary Care Providers Prescribe Medication Dosages For Children Using Which Of
The Following Information ( Select All That Apply)
A. Body Surface Area
B. Age
C. Weight
D. Developmental Age
E. Medication Properties - ANSWER:A,B,C,E
A Nurse Is Providing Teaching For A Client Who Has A New Prescription For A
Medication With A High Potential For Toxicity. Which Of The Following Information
Should The Nurse Include (Select All That Apply)
A. Periodic Laboratory Tests Are Essential To Measure Serum Medication Level &
Appropriate Dosage
B. Monitoring For Indications Of Toxicity Is Important
